354 related articles for article (PubMed ID: 27594736)
1. New Progress of Epigenetic Biomarkers in Urological Cancer.
Wu P; Cao Z; Wu S
Dis Markers; 2016; 2016():9864047. PubMed ID: 27594736
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers in urological tumors: A systematic review.
Jerónimo C; Henrique R
Cancer Lett; 2014 Jan; 342(2):264-74. PubMed ID: 22198482
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
4. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.
Angulo JC; López JI; Ropero S
Mol Diagn Ther; 2016 Dec; 20(6):531-549. PubMed ID: 27501813
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of Urological Cancers.
Schulz WA; Sørensen KD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561442
[TBL] [Abstract][Full Text] [Related]
6. [Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].
Heinzelmann J; Stubendorff B; Jung V; Baumgart S; Hölters S; Unteregger G; Grimm J; Linxweiler J; Janssen M; Ohlmann CH; Saar M; Siemer S; Stöckle M; Junker K
Urologe A; 2015 Jun; 54(6):832-8. PubMed ID: 26037021
[No Abstract] [Full Text] [Related]
7. Epigenetic extracellular vesicle-based biomarkers for urological malignancies: is the hope worth the hype?
Montezuma D; Teixeira-Marques A; Jerónimo C; Henrique R
Epigenomics; 2021 Oct; 13(19):1514-1521. PubMed ID: 34617453
[No Abstract] [Full Text] [Related]
8. DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
Larsen LK; Lind GE; Guldberg P; Dahl C
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151158
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as new diagnostic and prognostic biomarkers in urological tumors.
Fendler A; Jung K
Crit Rev Oncog; 2013; 18(4):289-302. PubMed ID: 23614616
[TBL] [Abstract][Full Text] [Related]
11. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of epigenetics in urological cancers.
Ramachandran K; Soloway MS; Singal R; Manoharan M
Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
[TBL] [Abstract][Full Text] [Related]
13. The study of DNA methylation in urological cancer: present and future.
Andrés G; Ashour N; Sánchez-Chapado M; Ropero S; Angulo JC
Actas Urol Esp; 2013 Jun; 37(6):368-75. PubMed ID: 23643196
[TBL] [Abstract][Full Text] [Related]
14. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
[TBL] [Abstract][Full Text] [Related]
15. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment.
Lotan Y; Merseburger AS
Curr Opin Urol; 2017 Jan; 27(1):34. PubMed ID: 27902674
[No Abstract] [Full Text] [Related]
17. The role of methylation in urological tumours.
van der Heijden AG
Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma.
Xiong G; Liu J; Tang Q; Fan Y; Fang D; Yang K; Xie F; Zhang M; Zhang L; Liu L; Zhang C; Yao L; Yang L; Ci W; Zhao W; Gong Y; He Q; Gong K; He Z; Wang G; Li X; Guo Y; Zhou L
Epigenomics; 2015 Aug; 7(5):733-44. PubMed ID: 25912368
[TBL] [Abstract][Full Text] [Related]
19. The translational potential of microRNAs as biofluid markers of urological tumours.
Fendler A; Stephan C; Yousef GM; Kristiansen G; Jung K
Nat Rev Urol; 2016 Dec; 13(12):734-752. PubMed ID: 27804986
[TBL] [Abstract][Full Text] [Related]
20. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
